New approaches to
rapid-onset antidepressants
by
Briner K, Dodel RC
Lilly Research Laboratory,
Eli Lilly and Company,
Indianapolis, IN 46285, USA.
briner_karin@lilly.com
Curr Pharm Des 1998 Aug; 4(4):291-302

ABSTRACT

The challenges for the design of new antidepressant drugs are threefold: rapid onset of antidepressant response, broader efficacy, and fewer adverse effects. While progress has been made to reduce side-effects, the currently available drugs show no convincing evidence for a shorter delay of onset nor for improved efficacy. This review summarizes some of the hypotheses that try to explain the delayed onset and that are currently used for antidepressant drug design. These approaches include combinations of SSRI activity with either NA reuptake inhibition or 5-HT1A-, 5-HT2-, or alpha 2-adrenergic receptor specificity, as well as targeting interactions with specific receptor subtypes (5-HT1A, 5-HT1A/5-HT2, 5-HT1B/D, alpha 2/5-HT2, D2/D3). Structure activity relationship studies to obtain molecular entities with the desired pharmacological profile are discussed. Many structural modifications have exploited successfully the acquired knowledge on structural features that are necessary for monoamine reuptake inhibition as well as for affinities at various receptors. Most of the current drug design efforts are focused on these approaches, which are based on the monoamine theory of depression; however, novel biological concepts of depression involving other receptor systems or intracellular targets are briefly mentioned. Although their impact on the onset of antidepressant response is only a matter of speculation at this moment, they may lead to the identification of targets for truly novel antidepressants.

Reward
Dopamine
Amineptine
More dopamine
New strategies
5-HT/dopamine
Vagus stimulation
New antidepressants
The pleasure and the pain
Antidepressant medication
Nitric oxide synthase inibitors
CFR 1 antagonists: antalarmin
Early-onset antidepressant strategies
Monoamines and 'novel' antidepressants
The future of depression psychopharmacology

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family